Citation Impact
Citing Papers
Strict Blood-Pressure Control and Progression of Renal Failure in Children
2009
Pathophysiology of Progressive Nephropathies
1998 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
1996 Standout
Recruitment experience in the full-scale phase of the modification of diet in renal disease study
1993
Effect of Gender on the Progression of Nondiabetic Renal Disease
2000
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
1999 Standout
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
The modification of diet in renal disease study group
1991
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Vitamin D Deficiency
2007 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Renal Protective Effects of Blocking the Intrarenal Renin-Angiotensin System.
1999
Dietary Protein Restriction and the Progression of Chronic Renal Disease
1999
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Does Accumulation of Advanced Glycation End Products Contribute to the Aging Phenotype?
2010
Diabetes in Asia
2009 Standout
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
1994 Standout
Cardiorenal Syndrome
2008 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Angiotensin-Converting Enzyme Inhibitor–Associated Elevations in Serum Creatinine
2000
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Measured Haplotype Analysis of the Angiotensin-I Converting Enzyme Gene
1998 StandoutNobel
Do We Need Gastric Acid?
2008
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Effect of a Very Low-Protein Diet on Outcomes: Long-term Follow-up of the Modification of Diet in Renal Disease (MDRD) Study
2008
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
The RAAS in the pathogenesis and treatment of diabetic nephropathy
2010
Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study
1996
Atherosclerosis
2000 StandoutNature
Surgical Interventions and Medical Treatments in Treatment-Naïve Patients With Acromegaly: Systematic Review and Meta-Analysis
2014
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Atherosclerosis
2001 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Low testosterone and anaemia in men with type 2 diabetes
2008
Frailty in elderly people
2013 Standout
Chronic Kidney Disease
2016 Standout
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism.
2002 StandoutNobel
Iron Metabolism in Ferroptosis
2020
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Cell Biology of the Glomerular Podocyte
2003 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
How should proteinuria be detected and measured?
2009
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate‐to‐severe reductions in renal function
2005
Chronic Kidney Disease Diagnosis and Management
2019 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Low protein diets for chronic kidney disease in non diabetic adults
2009
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
2013 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
A Consensus on Criteria for Cure of Acromegaly
2010
The Effect of Dietary Protein Restriction on the Progression of Diabetic and Nondiabetic Renal Diseases
1996
Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
2006 Standout
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
2006 Standout
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
1997 Standout
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease
2011
Controlled low protein diets in chronic renal insufficiency: meta-analysis.
1992
The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency
2003
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Progression, remission, regression of chronic renal diseases
2001
N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Prevents Renal Insufficiency and Mesangial Matrix Expansion in Diabetic db/db Mice
2005
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
Bone metabolism and disease in chronic kidney disease
2003
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Hematocrit, Independent of Chronic Kidney Disease, Predicts Adverse Cardiovascular Outcomes in Chinese Patients With Type 2 Diabetes
2006
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells
2005
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
2013 Standout
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of D. Alberti being referenced
Long-term progression of chronic renal insufficiency in the AIPRI extension study
1997
Hypertension as a factor in chronic renal insufficiency progression in polycystic kidney disease
1995
Proteinuria and blood pressure as causal components of progression to end-stage renal failure
1996
Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: An open-label, multicenter, non-comparative study
2005
Deferasirox is a powerful NF- B inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging
2010
Angiotensin-Converting Enzyme Inhibitors and Kidney Protection: The AIPRI Trial
1999
Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes
2004
Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency
1991
Deferasirox (Exjade®, ICL670) Demonstrates Dose-Related Effects on Body Iron Levels Related to Transfusional Iron Intake in Transfusion-Dependent Anemia.
2005
Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
1997